Osteoarthritis osteoporotic oa: A reasonable target for bone-acting agents

Nature Reviews Rheumatology

Volumn 9, Issue 8, 2013, Pages 448-450

  Herrero Beaumont, Gabriel ^a   Roman Blas, Jorge A ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; PARATHYROID HORMONE; RISEDRONIC ACID; STRONTIUM RANELATE;

BONE; BONE DENSITY; BONE REMODELING; BONE TURNOVER; CARTILAGE DEGENERATION; HUMAN; JOINT SPACE NARROWING; KNEE OSTEOARTHRITIS; KNEE PAIN; MUSCULOSKELETAL SYSTEM PARAMETERS; NONHUMAN; OSTEOARTHRITIS; OSTEOPOROSIS; OSTEOPOROTIC OSTEOARTHRITIS; PRIORITY JOURNAL; REVIEW; SUBCHONDRAL BONE; WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX;

EID: 84881132742     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2013.113     Document Type: Review

References (10)

1. Laslett, L. L., Kingsbury, S. R., Hensor, E. M., Bowes, M. A. & Conaghan, P. G. Effect of bisphosphonate use in patients with symptomatic and radiographic knee osteoarthritis: data from the Osteoarthritis Initiative. Ann. Rheum. Dis. http://dx.doi.org/10.1136/annrheumdis-2012-202989.
2. Kwoh, C. K. Clinical relevance of bone marrow lesions in OA. Nat. Rev. Rheumatol. 9, 7-8 (2013).
3. Goldring, S. R. & Goldring, M. B. Bone and cartilage in osteoarthritis: is what's best for one good or bad for the other? Arthritis Res. Ther. 12, 143 (2010).
4. Bellido, M. et al. Subchondral bone microstructural damage by increased remodelling aggravates experimental osteoarthritis preceded by osteoporosis. Arthritis Res. Ther. 12, R152 (2010).
5. Bellido, M. et al. Improving subchondral bone integrity reduces progression of cartilage damage in experimental osteoarthritis preceded by osteoporosis. Osteoarthritis Cartilage 19, 1228-1236 (2011).
6. Roemer, F. W. et al. Subchondral bone marrow lesions are highly associated with, and predict subchondral bone attrition longitudinally: the MOST study. Osteoarthritis Cartilage 18, 47-53 (2010).
7. Herrero-Beaumont, G., Roman-Blas, J. A., Castañeda, S. & Jimenez, S. A. Primary osteoarthritis no longer primary: three subsets with distinct etiological, clinical, and therapeutic characteristics. Semin. Arthritis Rheum. 39, 71-80 (2009).
8. Castañeda, S., Roman-Blas, J. A., Largo, R. & Herrero-Beaumont, G. What is osteoarthritis today? A progressive disease of changing phenotypes. Rheumatology (Oxford) (in press).
9. Buckland-Wright, J. C., Messent, E. A., Bingham, C. O. 3rd, Ward, R. J. & Tonkin, C. A 2 yr longitudinal radiographic study examining the effect of a bisphosphonate (risedronate) upon subchondral bone loss in osteoarthritic knee patients. Rheumatology (Oxford) 46,257-264 (2007).
10. Reginster, J. Y. et al. Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial. Ann. Rheum. Dis. 72, 179-186 (2013).